Position in MRK
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$300,012,291
+$24,719,485 QoQ
Shares Held
2,334,726
+2.0% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#101
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $4,331,881,187 across 11 Drug Manufacturers - General names. MRK ranks #5 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,891,125 | $1,242,199,016 | |
| 2 | LLY |
ELI LILLY & Co
|
1,003,469 | $1,203,590,923 | |
| 3 | ABBV |
AbbVie Inc.
|
2,578,333 | $648,811,716 | |
| 4 | AZN |
Astrazeneca PLC
|
1,621,109 | $307,394,688 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
2,334,726 | $300,012,291 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,971,583 | $249,089,796 | |
| 7 | AMGN |
Amgen Inc
|
420,259 | $152,184,189 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,007,448 | $115,669,153 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $300,012,291 | 2,334,726 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $275,292,806 | 2,288,576 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $234,816,218 | 2,230,821 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $174,473,263 | 2,078,795 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $157,627,507 | 1,991,252 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $200,338,485 | 2,231,935 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $237,179,121 | 2,384,189 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $284,643,476 | 2,506,547 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $642,565,701 | 5,190,353 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $681,563,314 | 5,165,315 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $587,380,571 | 5,387,824 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $517,543,650 | 5,027,136 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $571,519,976 | 4,952,942 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $517,756,083 | 4,866,586 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $276,514,915 | 2,492,248 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $226,995,439 | 2,635,804 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $257,741,053 | 2,827,038 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $241,270,321 | 2,940,528 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $240,081,390 | 3,132,586 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $239,487,934 | 3,188,496 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $237,518,756 | 3,054,118 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $270,464,089 | 3,508,418 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $431,472,146 | 5,274,723 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $448,180,300 | 5,403,015 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $418,883,800 | 5,416,832 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $344,381,834 | 4,475,981 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||